Opiate receptors have been solubilized from rat neural membranes and purified 500-fold (relative to the crude solubilized extract) by affinity chromatography. Active receptors were solubilized by using 3- [(3-cholamidopropyl and 2). The receptors are membrane-associated and their integrity appears dependent upon protein (3), carbohydrate (4), and phospholipid (5) components. The molecular dimensions of the receptors have been estimated in prelabeling experiments and more directly in partially purified preparations. Experiments in which opiate receptors were prelabeled with the potent agonist [3H]etorphine (6) or with u-selective radiolabeled enkephalin derivatives (7) prior to solubilization afforded a Mr estimate for the native receptor complex of 300,000-400,000. More recently, solubilization studies of an active receptor species from rat brain (8-10), toad brain (11), and cell culture (12, 13) have provided similar molecular weight estimates and suggest that the receptor is an aggregate of multiple protein components.
was achieved at -1 nM. Activity was markedly inhibited by protein modifying reagents, findings which suggest that the sites are proteinaceous. Opiate binding activity was also inhibited by the guanyl nucleotide GTP. Electrophoresis of the purified material under denaturing conditions revealed three subunits of molecular weights 94,000, 44,000, and 35,000. The inhibitory guanyl nucleotide binding protein (N1) implicated in opiate action has been shown to be comprised of two subunits of molecular weights 42,000 and 35,000. Thus, the opiate receptor may be an aggregate of multiple protein components that may include a guanyl nucleotide binding protein.
Biochemical, pharmacological, and behavioral studies provide compelling evidence that the actions of opiates and opioid peptides upon nervous tissue are mediated by interactions with lu, 8, and K receptors (for reviews, see refs. 1 and 2). The receptors are membrane-associated and their integrity appears dependent upon protein (3), carbohydrate (4) , and phospholipid (5) components. The molecular dimensions of the receptors have been estimated in prelabeling experiments and more directly in partially purified preparations. Experiments in which opiate receptors were prelabeled with the potent agonist [3H]etorphine (6) or with u-selective radiolabeled enkephalin derivatives (7) prior to solubilization afforded a Mr estimate for the native receptor complex of 300,000-400,000. More recently, solubilization studies of an active receptor species from rat brain (8) (9) (10) , toad brain (11) , and cell culture (12, 13) have provided similar molecular weight estimates and suggest that the receptor is an aggregate of multiple protein components.
Relatively little is known about the specific molecular properties of the three opiate receptor subtypes. Studies from our laboratory (10) indicate that the native 1L and K receptor complexes differ significantly in the macromolecular properties, including size, as estimated by molecular exclusion chromatography. In a study involving a highly selective, irreversible 8 ligand, Klee et al. (13) showed that the active subunit of the 8 receptor under denaturing conditions has a Mr of 58,000. On the basis of these studies, it is not possible to determine whether the pu, 8, and K receptors represent distinct polypeptide species or different aggregational states of the same protein component.
Purification and characterization of brain opiate receptors provides a direct means to elucidate the molecular properties that distinguish the receptor subtypes. However, this has been difficult to achieve in part because of the lack of. a tissue source highly enriched in these receptors. Attempts to purify 8 opiate receptors from a neuronal cell line (13) and K and ,t receptors from toad and mammalian brain using a wheat germ agglutinin column (14) and from rat brain using an affinity column (9) were generously donated by the National Institute on Drug Abuse. [3H]Etorphine was shown to be >97% pure by thin-layer chromatography. Levorphanol was a gift from Hoffman-La Roche. Trypsin, polyethylene glycol (PEG) 6000, and GTP were purchased from Sigma; CHAPS was from Calbiochem. Affi-Gel 401, NaDodSO4, electrophoresis-grade urea, N,N,N',N'-tetramethylethylenediamine, ammonium persulfate, Coomassie brilliant blue R-250, and the kit for silver staining were purchased from Bio-Rad. Marker proteins used for molecular weight calibrations were purchased from Pharmacia. The 1251I radioiodination system for protein iodination was purchased from New England Nuclear.
Solubilization of Opiate Receptors from Brain Neuronal Cells. Solubilization of brain opiate receptors was carried out as described (10) . P2 (mitochondrial/synaptosomal) membranes were prepared from the brains, minus the cerebellum, of male Sprague-Dawley rats (150-200 g). The P2 pellet was suspended in 2 vol of cold 10 mM Tris HCl buffer (pH 7.5). CHAPS was added to a final concentration of 10 mM and the suspension was homogenized on ice in a ground-glass homogenizer (10 strokes). After incubation on ice for 15 min, tTo whom reprint requests should be addressed. 594 the suspension was centrifuged at 105,000 x g for 60 min at 40C. The resulting clear supernatant (CHAPS extract) was applied immediately to the affinity column or stored at -70'C. The CHAPS extract prepared in this way was assayed for opiate binding activity by using the PEG method (10) after a 1:10 dilution into Tris-HCl buffer (pH 7.5), as described in the legend to Table 2 .
Synthesis of 7a-{(lR)-Hydroxy-l-Methyl-3-p-[4-(3'-Bromomercuri-2'-Methoxy-Propoxy)-Phenyl]-Propyl}-6,14-Endoethenotetrahydrothebaine (Hybromet). The synthesis of hybromet 4 was carried out as shown in Fig. 1 . p-Hydroxyphenylethyl alcohol was condensed with allyl bromide to give p-allyloxyphenylethyl alcohol. This alcohol was converted to a crystalline tosylate (mp, 390C), which, on refluxing with sodium iodide in acetone solution, afforded the corresponding iodide. The latter was converted to the Grignard reagent 2, which was allowed to react with 7a-acetyl-6,14-endoethenothebaine 6, obtained by condensing thebaine with methyl vinyl ketone as described by Bentley et al. (15, 16) to give the crystalline adduct 3 (mp, 160-1620C).
Mercuration in chloroform/methanol solution with mercuric acetate followed by treatment with potassium bromide gave the desired bromomercuri compound (mp, 117-113'C). The NMR and IR spectra as well as the elemental analyses of the new compounds agree with the structural assignments.
Purification of Active Opiate Receptors Using Affinity Chromatography. The CHAPS-solubilized receptors have been purified by specific adsorption on an affinity column consisting of Affi-Gel 401 (a sulfhydryl derivative of agarose) to which the opiate analog (hybromet) is attached. Specific elution of u receptors was achieved by using the selective ,u opioid normorphine (1 AM). For preparation of the column, preswollen Affi-Gel 401 was washed with 0.1 M NaHCO3 on a glass fiber filter, suspended in 250 ml of 0.5 M NaCl, and filtered. The gel was resuspended in 15 ml of cold 0.1 M NaHCO3; 40 mg of the synthetic ligand, hybromet, was added, and the suspension was shaken gently at 4°C for 16 hr. After incubation with the ligand, the gel was allowed to settle, excess buffer was removed, and the gel was taken up in 15 ml of fresh 0.1 M NaHCO3. The gel was then poured into a column (1.5 x 3.5 cm; total volume, 6 ml) and equilibrated with 300 ml of 10 mM Tris HCl buffer (pH 7.5) before use.
For purification of the receptors by affinity chromatography, 40-50 mg of CHAPS extract was incubated at 37°C for 30 min to facilitate the dissociation of endogenous opioid ligands. The sample was then applied to the column and eluted with 10 mM Tris HCl buffer (pH 7.5) containing 1 mM NCH3 (17) using bovine serum albumin as standard or were monitored in column eluates by measuring absorbance at 225 nm. Polyacrylamide Gel Electrophoresis (PAGE). The purified receptor preparations were examined under nondenaturing conditions by PAGE using a 5% resolving gel in the presence of 1 mM CHAPS at 40C according to the method of Davis (18) . Samples (-40 Ag) were analyzed under denaturing conditions by NaDodSO4/PAGE, using a 10% polyacrylamide resolving gel and a 5% stacking gel at room temperature according to the method of Laemmli (19) . Proteins were visualized by silver staining (20) . In a separate experiment, the purified receptor preparation was iodinated with 125I using the radioiodination system from New England Nuclear and analyzed by NaDodSO4/PAGE as before. The slab gel was stained with the silver stain, dried under vacuum, and exposed to Kodak X-Omat AR film for 4 days at -70'C to visualize the 1251-containing subunits.
RESULTS
Purification of Opiate Receptors from Rat Brain. Opiate receptors were solubilized in an active state from rat neural membranes using the zwitterionic detergent CHAPS. The solubilized extract was purified by affinity chromatography using Affi-Gel 401 (sulfhydryl derivative of agarose) to which hybromet (step 4 of Fig. 1 ), an opioid ligand with high affinity for the ,u receptor, had been attached. Elution was achieved by using 12 column vol of 10 mM Tris HCl buffer (pH 7.5) containing 1 mM CHAPS at 4°C, followed by buffer to which 1 ,uM normorphine had been added. Normorphine was chosen for specific elution of the A opioid receptor because of its high selectivity for that receptor (2) . The elution profile is shown in Fig. 2 . Opiate receptor activity, as measured by the stereospecific binding of [3H]etorphine, migrated as two peaks. The first, the minor peak of receptor activity, was eluted with buffer alone and migrated just following the major protein peak; this activity peak most likely represents unretarded receptor protein that did not adhere to the affinity column. The second and major peak of [3H]etorphine binding activity appeared following addition of normorphine (1 ,uM) to the elution buffer. Fractions corresponding to this second peak were pooled, concentrated, and dialyzed to remove the normorphine.
[3H]Etorphine binding to the partially purified opiate receptors was studied as a function of radioligand concentration. Half-maximal binding was observed at -1 nM radioligand. Scatchard analysis (Fig. 3) Effects of Protease Inhibitors on the Stability of the Solubilized Receptors. Fig. 4 shows the opiate receptor activity levels of the CHAPS extract as a function of time. At specified times, samples stored at -20TC were thawed and assayed for opiate binding by using the PEG method. In the absence of added reagents, activity levels were observed to decrease markedly in the first 24 hr to <10% of the activity observed immediately after solubilization. Addition of protease inhibitors Trasylol (200 units/mil), leupeptin (50 ,ug/ml), and EDTA (10 mM) to the diluted CHAPS extract immediately after the ultracentrifugation step prevented this loss of activity. CHAPS extract to which the inhibitors had been-added exhibited 100% of the original binding activity 5 days after solubilization. In the case in which receptors were purified in the absence of protease inhibitors and the inhibitors were added after the affinity chromatography step tAssayed on day 5 following solubilization. tThe fold purification is reported relative to the activity of the CHAPS extract assayed on day 5 following solubilization. Specific binding of [3H] etotphine to the purified affinity column active fractions was measured by the PEG method (10) . Tubes in triplicate cofitaining 2 nM tritiated ligand, purified receptor, and 10 nM Tris HCI (pH 7.4) were incubated in the presence and absence of unlabeled ligand (levorphanol) at 370C for 20 min. At the end of the incubation, 4d A.l of 1% gamma globulin were added to each tube, followed by 1 ml of 21% PEG 6000 in 100 mM KOAc (pH 5.6).
Samples were incubated an additional 10 min at 40C. Free ligand was separated from the protein-bound ligand by filtration under reduced pressure through Whatman GV/I1 filters and the filters were washed twice with 5 ml of buffer containing 7% PEG. Bound radioactivity was determined by liquid scintillation counting. Nonspecific binding was measured in the presence of a large excess of unlabeled ligand.
approximate Mr of 300,000-350,000, in confirmation of earlier reports based on molecular exclusion chromatography (6, 7) . On exposure to NaDodSO4 and reducing conditions, this band resolved into a major subunit ofMr -94,000 as well as faint bands at positions corresponding to Mr 44,000 and Mr 35,000 (Fig. 5) . Identical results were obtained whether the protein bands were visualized by silver staining (Fig. 5,  lane 4) or by radioautography after 1251 incorporation (Pig. 5, lane 5). This experiment was replicated in five different preparations. In a preliminary experiment, the affinitypurified receptor preparation was applied to a hydroxylapatite column; elution with a phosphate buffer gradient afforded an active receptor species. When this hydroxylapatite-purified receptor was analyzed on NaDodSO4 /PAGE only the Mr 94,000 subunit was obtained (Fig. 5, lane  6) , a result which suggests that this subunit may be responsible for ligand binding. NaDodSO4/PAGE performed on the crude extract, CHAPS extract, and various pools of the affinity column fractions clearly showed the effective removal of protein by affinity chromatography (Fig. 5) . Finally, in a preliminary study, antibodies were raised to the affinity-purified receptor in female rabbits. Immuno 
DISCUSSION
We have purified A opiate receptors from rat brain -500-fold using an affinity column in which hybromet, an opioid ligand which binds to the jz receptor with high affinity, has been coupled to a sulfhydryl derivative of agarose beads. A single sharp peak of opiate binding activity was observed following normorphine elution. Although the specificity of hybromet has not been assessed, specificity of the purified receptor was achieved by elution with normorphine. Normorphine has been shown to be a highly selective Au ligand (2) with very low affinity for 8 receptors and no detectable affinity for K receptors. K receptor binding activity was <10% of the A receptor activity. The pooled, concentrated fractions exhibited high affinity (Kd = 1.4 nM). The density of opiate receptors in rat brain membranes (as measured by using the nonselective opioid [3H]etorphine) is =200 fmol/mg of protein. Using radiolabeled enkephalin analogs to label opiate receptors, we had estimated a Mr of 300,000-400,000 (6, 7) . Assuming this molecular weight and one binding site per receptor molecule, then 100 mg of protein (or the tissue from one adult rat brain) would be expected to contain =10 ,Ag of receptor. Thus, a much greater purification than has been achieved (on the basis of receptor activity) is necessary to achieve a homogenous receptor preparation. We have found that during the 6-day purification, concentration, and dialysis procedure, >90% of the original opiate receptor activity is lost (at 40C) in the CHAPS extract. Thus, the actual fold purification of the receptor molecules may have been greatly underestimated. Assuming a correction for the loss of receptor activity, we calculate that the fold purification would be increased by a factor of at least 10 or even 100, which would be sufficient to account for a homogeneous preparation of the receptor. In preliminary experiments, we have achieved Neurobiology: Maneckjee et al.
"Olk a 1300-fold purification of the receptor using an hydroxylapatite column; this column will now be used sequentially with the affinity column step.
Solubilization of 8 opiate receptors from the neuroblastoma-glioma hybrid cell line NG-108-15 (12), K receptors from toad brain (11) , and ,u and K receptors from mammalian brain have been described (4, 8, 10 shown to be 58,000. Simon and co-workers (14) achieved a 30-fold purification using a wheat germ agglutinin-agarose column. Abood's group (9), using an affinity column in Which 14-/3-bromacetamidomorphine had been linked to &o-aminohexyl-Sepharose, achieved considerable purification of opiate binding activity, although background binding was high. The uniqueness of our preparation resides in the high signal-to-noise or percent specific binding (>75%) and high fold purification.
Many of these properties of the purified g receptors were found to be similar to those of the membrane-associated receptors, including (i) sensitivity to protein-modifying agents, (it) modulation by guanyl nucleotides, and (iii) affinity for opioid ligands. Activity was markedly inhibited by heat and trypsin, findings which suggest that the sites are proteinaceous. Opiate binding activity was also inhibited by the guanyl nucleotide GTP. The findings of (a) a lack of 8 receptor activity and (b) a very low level of K receptor activity in affinity-purified fractions indicate that the purified receptor is p-specific. The possibility does exist that under other ionic conditions (10), 8 receptor activity might be unmasked. Electrophoresis of the affinity-purified opiate receptors under denaturing conditions revealed three bands corresponding to Mr of 94,000, 44,000, and 35,000. Our findings of Mr 35,000 and Mr 44,000 subunits are consistent with those of Bidlack et al. (9) , although we were unable to visualize the bands with Coomassie blue staining. The finding of a Mr 35,000 subunit is also consistent with our previous finding that a Mr 35,000 species was covalently labeled by relatively pi-selective [3H]enkephalin derivatives (i), The exact subunit structure for the g receptor remains to be determined.
It may seem surprising to obtain such apparent homogeneity after such a low fold purification. A major reason for this low specific activity may be the progressive loss of activity observed throughout the purification procedure, as a result of proteolytic digestion. There are similar reports in the literature where such inactivation occurs (21, 22) . The inclusion of protease inhibitors markedly retarded this activity loss. Unfortunately, these inhibitors also inhibited opiate binding to the purified receptor and significantly inhibited the specific adsorption of the receptor to the affinity column resulting in a lowered column efficiency. Another factor contributing to the overall low yields may be the inability of 1 ,uM normorphine to elute all of the bound receptor from the affinity column. In this regard, higher concentration of normorphine improved the yield modestly. It is also possible that one or more of the bands may be contaminating proteins or degradation products of the active molecule. As mentioned in the Results, only the Mr 94,000 subunit was obtained on NaDodSO4/PAGE of the purified active fraction after further purification on a hydroxylapatite column (preliminary data). Thus, it is intriguing to speculate that the ponent and that the Mr 44,000 and Mr 35,000 species represent the subunits of the inhibitory guanyl nucleotide binding protein (Ni) implicated in opiate action (23) (24) (25) .
In summary, opiate receptors from rat brain have been partially purified by affinity chromatography. The resulting PAGE analysis and sensitivity to guanyl nucleotides are consistent with a large heteroligomer, which may contain, in part, the Ni protein.
Note Added in Proof. After submission of this manuscript, Gioannini et al. (26) reported a 300-fold purification of opioid binding using CH-Sepharose modified with a new naltrexone derivative, (3-naltrexyl-6-ethylene-diamine, and elution with naloxone.
